Assessing Liver Function in Patients with HCC - Episode 6

Updates in First-Line Systemic Therapy for Patients With HCC

, ,

Arndt Vogel, MD, discusses the post-hoc analyses of two key clinical trials focusing on the impact of liver function, measured by ALBI and Child-Pugh scores, on outcomes in hepatocellular carcinoma treatments.